Literature DB >> 9777949

Microsatellite instability and mutation of DNA mismatch repair genes in gliomas.

S Y Leung1, T L Chan, L P Chung, A S Chan, Y W Fan, K N Hung, W K Kwong, J W Ho, S T Yuen.   

Abstract

Microsatellite instability (MSI) has been identified in various human cancers, particularly those associated with the hereditary nonpolyposis colorectal cancer syndrome. Although gliomas have been reported in a few hereditary nonpolyposis colorectal cancer syndrome kindred, data on the incidence of MSI in gliomas are conflicting, and the nature of the mismatch repair (MMR) defect is not known. We established the incidence of MSI and the underlying MMR gene mutation in 22 patients ages 45 years or less with sporadic high-grade gliomas (17 glioblastomas, 3 anaplastic astrocytomas, and 2 mixed gliomas, grade III). Using five microsatellite loci, four patients (18%) had high level MSI, with at least 40% unstable loci. Germline MMR gene mutation was detected in all four patients, with inactivation of the second allele of the corresponding MMR gene or loss of protein expression in the tumor tissue. Frameshift mutation in the mononucleotide tract of insulin-like growth factor type II receptor was found in one high-level MSI glioma, but none was found in the transforming growth factor beta type II receptor and the Bax genes. There was no family history of cancer in three of the patients, and although one patient did have a family history of colorectal carcinoma, the case did not satisfy the Amsterdam criteria for hereditary nonpolyposis colorectal cancer syndrome. Three patients developed metachronous colorectal adenocarcinomas, fitting the criteria of Turcot's syndrome. Thus, MSI and germline MMR gene mutation is present in a subset of young glioma patients, and these patients and their family members are at risk of developing other hereditary nonpolyposis colorectal cancer syndrome-related tumors, in particular colorectal carcinomas. These results have important implications in the genetic testing and management of young patients with glioma and their families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777949      PMCID: PMC1853047          DOI: 10.1016/S0002-9440(10)65662-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Tumors of the central nervous system in Taiwan, Republic of China.

Authors:  J J Kepes; W Y Chen; L C Pang; M Kepes
Journal:  Surg Neurol       Date:  1984-08

2.  Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.

Authors:  S Izumoto; N Arita; T Ohnishi; S Hiraga; T Taki; N Tomita; M Ohue; T Hayakawa
Journal:  Cancer Lett       Date:  1997-01-30       Impact factor: 8.679

3.  The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum.

Authors:  H Ouyang; H O Shiwaku; H Hagiwara; K Miura; T Abe; Y Kato; H Ohtani; K Shiiba; R F Souza; S J Meltzer; A Horii
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

4.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

Review 5.  Microsatellite instability in inherited and sporadic neoplasms.

Authors:  J R Eshleman; S D Markowitz
Journal:  Curr Opin Oncol       Date:  1995-01       Impact factor: 3.645

6.  A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

Authors:  L L Myeroff; R Parsons; S J Kim; L Hedrick; K R Cho; K Orth; M Mathis; K W Kinzler; J Lutterbaugh; K Park
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

7.  GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.

Authors:  F Palombo; P Gallinari; I Iaccarino; T Lettieri; M Hughes; A D'Arrigo; O Truong; J J Hsuan; J Jiricny
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

8.  Mutations of GTBP in genetically unstable cells.

Authors:  N Papadopoulos; N C Nicolaides; B Liu; R Parsons; C Lengauer; F Palombo; A D'Arrigo; S Markowitz; J K Willson; K W Kinzler
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

9.  Tumours of the central nervous system in Chinese in Hong Kong: a histological review.

Authors:  H K Ng; W S Poon; J R South; J C Lee
Journal:  Aust N Z J Surg       Date:  1988-07

10.  Colorectal carcinoma in Hong Kong: epidemiology and genetic mutations.

Authors:  S T Yuen; L P Chung; S Y Leung; I S Luk; S Y Chan; J C Ho; J W Ho; A H Wyllie
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  28 in total

Review 1.  Genomic imprinting: implications for human disease.

Authors:  J G Falls; D J Pulford; A A Wylie; R L Jirtle
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Establishment and characterization of nine human brain tumor cell lines.

Authors:  K H Shin; G Choe; Y J Park; J H Jang; H W Jung; J G Park
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

3.  Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group.

Authors:  Ian F Pollack; Ronald L Hamilton; Robert W Sobol; Marina N Nikiforova; Yuri E Nikiforov; Maureen A Lyons-Weiler; William A LaFramboise; Peter C Burger; Daniel J Brat; Marc K Rosenblum; Floyd H Gilles; Allan J Yates; Tianni Zhou; Kenneth J Cohen; Jonathan L Finlay; Regina I Jakacki
Journal:  Pediatr Blood Cancer       Date:  2010-12-01       Impact factor: 3.167

Review 4.  PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Authors:  Mustafa Khasraw; David A Reardon; Michael Weller; John H Sampson
Journal:  Clin Cancer Res       Date:  2020-06-11       Impact factor: 12.531

5.  Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.

Authors:  Mahmoud R Hussein; Rabab M H El-Ghorori; Yasser G Abd El-Rahman
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

Review 6.  Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.

Authors:  Valerie Lee; Adrian Murphy; Dung T Le; Luis A Diaz
Journal:  Oncologist       Date:  2016-07-13

7.  Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.

Authors:  S Lescop; A Lellouch-Tubiana; G Vassal; C Besnard-Guerin
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

Review 8.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?

Authors:  Katharina Wimmer; Julia Etzler
Journal:  Hum Genet       Date:  2008-08-18       Impact factor: 4.132

9.  Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.

Authors:  Alison E Gammie; Naz Erdeniz; Julia Beaver; Barbara Devlin; Afshan Nanji; Mark D Rose
Journal:  Genetics       Date:  2007-08-24       Impact factor: 4.562

10.  Automated mass action model space generation and analysis methods for two-reactant combinatorially complex equilibriums: an analysis of ATP-induced ribonucleotide reductase R1 hexamerization data.

Authors:  Tomas Radivoyevitch
Journal:  Biol Direct       Date:  2009-12-09       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.